Corbus Pharmaceuticals
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
500 River Ridge Dr, Norwood, Massachuset...Phone Number
(617) 963-0100Website
www.corbuspharma.comRevenue
<$5 MillionStock Symbol
CRBPIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Corbus Pharmaceuticals
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E (MMAE), which is in Phase I clinical trial; CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells for the treatment of solid tumors; CRB-913, a peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, including the Jenrin library of approximately 600 compounds, and multiple issued and pending patent filings. The company was incorporated in 2009 and is based in Norwood, Massachusetts.Explore more
Corbus Pharmaceuticals Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Corbus Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Corbus Pharmaceuticals launches new products
Check if Corbus Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Corbus Pharmaceuticals
Funding: Get notified immidiatlly once Corbus Pharmaceuticals has new funding data
Click to see if Corbus Pharmaceuticals had a recent Job posting/layoffs
Earning: See what the market has to say on Corbus Pharmaceuticals recently announced quarterly report
Check out if Corbus Pharmaceuticals is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Corbus Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Corbus Pharmaceuticals as Masked Content
Find more new buyers
Compare Similar Companies to Corbus Pharmaceuticals
Compare insights from companies similar to Corbus Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Corbus Pharmaceuticals is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Corbus Pharmaceuticals is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Corbus Pharmaceuticals.
Corbus Pharmaceuticals financials insights
Gather financial insights about Corbus Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$50M
2024
Share Placement
$16.8M
Corbus Pharmaceuticals Tech Stack
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Person-Based
Earnings, Finance, Investor Relations
Person-Based
Person-Based
Person-Based
Medical Research, Pharmaceuticals, Clinical Operations
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Corbus Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E (MMAE), which is in Phase I clinical trial; CRB-601, an anti-integrin... Read More
